Moberg Pharma: First market approval - Redeye

Redeye is encouraged by the news that Ireland is the first market to receive national approval for MOB-015 after the decentralized procedure that was concluded earlier. This is positive as it shows that the process is proceeding with national approvals coming during the following months and takes away any uncertainty that approvals will come.

Länk till analysen i sin helhet: https://www.redeye.se/research/926786/moberg-pharma-first-market-approval?utm_source=finwire&utm_medium=RSS